Capricorn Fund Managers Ltd
13F filer · CIK 0001901361Reported Jul 24, 2026
Net buyer this quarter
13F portfolio value$1.27BU.S. long equity reported on 13F
Positions16794 new · 38 closed
Net flow last quarter+$541MBuys minus sells
Top 10 positions weight27.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 24, 2026167 positions | |||||
| $54.9M | 4.33% | 0.24% | New | Q2 2026 | |
| $42.2M | 3.33% | 0.05% | +117.0% | Q1 2026 | |
| $36.4M | 2.87% | Not reported | Not reported | Q1 2022 | |
| $35.6M | 2.81% | 0.01% | Not reported | Q1 2022 | |
| $31.6M | 2.49% | 0.02% | Not reported | Q4 2025 | |
| $31.3M | 2.46% | Not reported | Not reported | Q1 2026 | |
| $29.1M | 2.29% | 75000000.00% | New | Q2 2026 | |
| $28.2M | 2.23% | 0.03% | Not reported | Q3 2023 | |
| $26.9M | 2.12% | 0.02% | +196.1% | Q1 2025 | |
| $26.1M | 2.05% | 0.01% | -14.8% | Q1 2022 | |
| $25.3M | 1.99% | 0.66% | New | Q2 2026 | |
| $23.4M | 1.84% | 0.26% | New | Q2 2026 | |
| $22.4M | 1.76% | 0.01% | New | Q2 2026 | |
| $22.1M | 1.74% | 0.07% | New | Q2 2026 | |
| $21.5M | 1.69% | 0.87% | -32.4% | Q1 2026 | |
| $21.1M | 1.66% | 0.00% | New | Q2 2026 | |
| $20.8M | 1.64% | Not reported | New | Q2 2026 | |
| $19.3M | 1.53% | 4.78% | +74.1% | Q1 2026 | |
| $18.3M | 1.44% | 0.34% | New | Q2 2026 | |
| $17.9M | 1.41% | 0.00% | Not reported | Q2 2023 | |
| $17.7M | 1.39% | 0.07% | +86.0% | Q1 2026 | |
| $17.1M | 1.35% | 0.21% | New | Q2 2026 | |
| $15.8M | 1.24% | 1.03% | +14.7% | Q4 2024 | |
| $15.4M | 1.22% | 17.12% | +14.8% | Q1 2026 | |
| $15.2M | 1.20% | 0.01% | New | Q2 2026 | |
| $14.7M | 1.16% | 4.93% | -21.0% | Q1 2026 | |
| $14.5M | 1.15% | 0.20% | -26.4% | Q1 2026 | |
| $14.4M | 1.13% | 0.08% | Not reported | Q3 2023 | |
| $14.2M | 1.12% | 0.04% | New | Q2 2026 | |
| $13.4M | 1.06% | 0.06% | +37.5% | Q4 2024 | |
| $12.7M | 1.00% | 0.68% | -51.7% | Q4 2025 | |
| $12.7M | 1.00% | 0.02% | New | Q2 2026 | |
| $12.2M | 0.96% | 0.30% | New | Q2 2026 | |
| $12.1M | 0.95% | 0.00% | Not reported | Q4 2021 | |
| $11.9M | 0.93% | 0.16% | New | Q2 2026 | |
| $11.2M | 0.89% | Not reported | Not reported | Q1 2022 | |
| $11.1M | 0.88% | 0.00% | Not reported | Q4 2021 | |
| $10.6M | 0.84% | 0.00% | Not reported | Q2 2022 | |
| $10.5M | 0.83% | 0.06% | Not reported | Q1 2022 | |
| $10.4M | 0.82% | Not reported | Not reported | Q1 2022 | |
| $10.3M | 0.81% | 0.06% | Not reported | Q1 2024 | |
| $10.2M | 0.80% | 0.05% | +62.2% | Q4 2024 | |
| $10.1M | 0.80% | 0.01% | New | Q2 2026 | |
| $10.1M | 0.79% | 7.73% | Not reported | Q1 2026 | |
| $10M | 0.79% | 0.03% | New | Q2 2026 | |
| $8.41M | 0.66% | 0.20% | -57.3% | Q1 2026 | |
| $8.02M | 0.63% | 0.14% | New | Q2 2026 | |
| $7.64M | 0.60% | 0.08% | +240.0% | Q4 2024 | |
| $7.6M | 0.60% | Not reported | Not reported | Q4 2021 | |
| $7.29M | 0.57% | 0.51% | New | Q2 2026 | |
| Q1 2026Reported Apr 24, 2026111 positions | |||||
| $29.9M | 4.66% | Not reported | New | Q1 2026 | |
| $26.2M | 4.08% | 0.01% | +2008.8% | Q1 2022 | |
| $25.2M | 3.93% | 1.38% | -1.5% | Q4 2025 | |
| $22.8M | 3.55% | 1.29% | New | Q1 2026 | |
| $19.6M | 3.06% | 0.02% | New | Q1 2026 | |
| $18.9M | 2.95% | 0.46% | New | Q1 2026 | |
| $18.6M | 2.90% | 6.24% | New | Q1 2026 | |
| $17.9M | 2.80% | 0.81% | New | Q1 2026 | |
| $17.5M | 2.73% | 0.03% | +144.5% | Q4 2025 | |
| $17.3M | 2.69% | 15.03% | New | Q1 2026 | |
| $17M | 2.66% | 0.22% | New | Q1 2026 | |
| EAEAElectronic Arts Inc. | $15.5M | 2.41% | Not reported | +96.9% | Q4 2025 |
| $14.8M | 2.30% | 0.39% | +45.1% | Q3 2025 | |
| $14.5M | 2.26% | 0.61% | New | Q1 2026 | |
| $13.9M | 2.16% | 0.90% | +16.9% | Q4 2024 | |
| $12M | 1.87% | 0.00% | +12.6% | Q4 2021 | |
| CIGTLSChart Industries Inc | $11.8M | 1.84% | 0.12% | +70.7% | Q4 2025 |
| $11M | 1.72% | 2.63% | New | Q1 2026 | |
| $10.8M | 1.68% | Not reported | +89.5% | Q1 2022 | |
| $9.34M | 1.46% | 0.28% | New | Q1 2026 | |
| $9.3M | 1.45% | 0.00% | -6.3% | Q2 2022 | |
| $8.93M | 1.39% | 0.00% | 0.0% | Q4 2021 | |
| $8.83M | 1.38% | 0.14% | +70.6% | Q4 2025 | |
| $8.81M | 1.37% | 0.06% | +599.4% | Q1 2024 | |
| $8.6M | 1.34% | 0.01% | Not reported | Q1 2025 | |
| $8.56M | 1.33% | 0.05% | New | Q1 2026 | |
| $8.31M | 1.30% | 0.00% | +104.6% | Q4 2021 | |
| $8.16M | 1.27% | 0.03% | New | Q1 2026 | |
| $8.15M | 1.27% | 0.75% | +35.5% | Q4 2024 | |
| $8.13M | 1.27% | 0.07% | New | Q1 2026 | |
| $7.72M | 1.20% | Not reported | +49.7% | Q4 2021 | |
| ATFOLDAmicus Therapeutics, Inc. | $7.72M | 1.20% | 0.17% | +153.5% | Q4 2025 |
| $7.52M | 1.17% | 0.04% | New | Q1 2026 | |
| $6.78M | 1.06% | 0.05% | Not reported | Q4 2024 | |
| $6.09M | 0.95% | 0.03% | +711.4% | Q4 2024 | |
| $5.96M | 0.93% | 0.00% | Not reported | Q4 2023 | |
| $5.91M | 0.92% | 0.00% | -13.6% | Q2 2022 | |
| $5.76M | 0.90% | 7.65% | New | Q1 2026 | |
| $5.68M | 0.89% | 0.01% | +71.8% | Q2 2024 | |
| $4.98M | 0.78% | 0.01% | New | Q1 2026 | |
| $4.98M | 0.78% | 0.46% | +39.7% | Q1 2022 | |
| HHOLXHologic Inc | $4.9M | 0.76% | 0.03% | New | Q1 2026 |
| $4.85M | 0.76% | 0.08% | New | Q1 2026 | |
| $4.81M | 0.75% | 0.02% | Not reported | Q1 2025 | |
| $4.75M | 0.74% | 0.05% | Not reported | Q4 2024 | |
| $4.65M | 0.73% | 0.00% | +0.1% | Q4 2021 | |
| $4.57M | 0.71% | Not reported | Not reported | Q2 2025 | |
| $4.55M | 0.71% | 0.17% | Not reported | Q2 2025 | |
| $4.53M | 0.71% | 0.06% | +6.2% | Q4 2025 | |
| MMASIMasimo Corp | $4.06M | 0.63% | 0.04% | New | Q1 2026 |
| Q4 2025Reported Jan 21, 202678 positions | |||||
| $26.9M | 6.49% | 1.37% | New | Q4 2025 | |
| $24.2M | 5.83% | 0.39% | +46.2% | Q3 2025 | |
| $17.6M | 4.23% | 0.12% | New | Q4 2025 | |
| $14.2M | 3.43% | 0.46% | New | Q4 2025 | |
| $13.9M | 3.35% | 0.00% | +5.2% | Q4 2021 | |
| $11M | 2.65% | 0.08% | +197.8% | Q3 2025 | |
| $11M | 2.65% | 0.00% | +7.3% | Q2 2022 | |
| $10.8M | 2.61% | 0.77% | +39.4% | Q4 2024 | |
| $9.82M | 2.37% | 0.04% | New | Q4 2025 | |
| $9.72M | 2.34% | 0.00% | -34.1% | Q4 2021 | |
| $9.67M | 2.33% | 0.06% | +124.4% | Q3 2025 | |
| $9.15M | 2.21% | 0.79% | New | Q4 2025 | |
| $8.32M | 2.00% | 0.03% | New | Q4 2025 | |
| $7.94M | 1.91% | 0.00% | +12.4% | Q2 2022 | |
| $7.94M | 1.91% | 0.16% | New | Q4 2025 | |
| EAEAElectronic Arts Inc. | $7.88M | 1.90% | Not reported | New | Q4 2025 |
| $7.22M | 1.74% | 0.01% | New | Q4 2025 | |
| $6.94M | 1.67% | 0.20% | New | Q4 2025 | |
| $6.93M | 1.67% | 0.09% | New | Q4 2025 | |
| CIGTLSChart Industries Inc | $6.88M | 1.66% | 0.07% | New | Q4 2025 |
| $6.88M | 1.66% | 0.27% | -27.2% | Q3 2025 | |
| $6.77M | 1.63% | 0.10% | New | Q4 2025 | |
| $6.3M | 1.52% | 0.55% | +12.2% | Q4 2024 | |
| $6.2M | 1.49% | 0.33% | -67.0% | Q1 2022 | |
| TPTERNTerns Pharmaceuticals, Inc. | $6.12M | 1.47% | 0.13% | New | Q4 2025 |
| $5.96M | 1.44% | Not reported | -8.4% | Q1 2022 | |
| $5.95M | 1.43% | Not reported | -30.9% | Q4 2021 | |
| DDAYDayforce, Inc. | $5.88M | 1.42% | 0.05% | New | Q4 2025 |
| $5.21M | 1.26% | 0.08% | New | Q4 2025 | |
| ABRNAMAvidity Biosciences, Inc. | $4.94M | 1.19% | 0.05% | +533.9% | Q3 2025 |
| $4.87M | 1.17% | 0.01% | New | Q4 2025 | |
| $4.76M | 1.15% | 0.07% | New | Q4 2025 | |
| $4.72M | 1.14% | 0.01% | New | Q4 2025 | |
| $4.44M | 1.07% | 0.02% | -8.2% | Q1 2025 | |
| $4.3M | 1.04% | 0.01% | +123.1% | Q2 2024 | |
| $4.12M | 0.99% | 0.00% | Not reported | Q4 2021 | |
| $4.04M | 0.97% | 0.00% | New | Q4 2025 | |
| CCFLTConfluent, Inc. | $3.94M | 0.95% | 0.12% | New | Q4 2025 |
| $3.91M | 0.94% | 0.00% | -7.1% | Q4 2023 | |
| HHIHillenbrand, Inc. | $3.9M | 0.94% | 0.17% | New | Q4 2025 |
| $3.84M | 0.93% | 0.03% | New | Q4 2025 | |
| $3.76M | 0.91% | 0.00% | -28.7% | Q4 2021 | |
| $3.75M | 0.90% | 0.05% | New | Q4 2025 | |
| $3.74M | 0.90% | 0.12% | New | Q4 2025 | |
| $3.46M | 0.83% | 0.00% | -8.1% | Q3 2023 | |
| $3.16M | 0.76% | 0.01% | -9.1% | Q4 2024 | |
| CACWANClearwater Analytics Holdings, Inc. | $3.01M | 0.72% | Not reported | New | Q4 2025 |
| ATFOLDAmicus Therapeutics, Inc. | $3M | 0.72% | 0.07% | New | Q4 2025 |
| $2.66M | 0.64% | 0.00% | New | Q4 2025 | |
| $2.58M | 0.62% | 0.04% | New | Q4 2025 | |
| Q3 2025Reported Oct 17, 202557 positions | |||||
| $19.2M | 6.43% | 0.29% | New | Q3 2025 | |
| $14.3M | 4.79% | 0.57% | New | Q3 2025 | |
| $14.1M | 4.75% | 0.00% | +26.4% | Q4 2021 | |
| $13.1M | 4.40% | 0.71% | New | Q3 2025 | |
| $12.6M | 4.25% | 1.02% | -26.0% | Q1 2022 | |
| $11.5M | 3.85% | 0.00% | -3.9% | Q4 2021 | |
| $11.4M | 3.83% | 0.81% | New | Q3 2025 | |
| $10.7M | 3.58% | 0.10% | New | Q3 2025 | |
| $10.3M | 3.44% | 0.07% | New | Q3 2025 | |
| $10.2M | 3.44% | 0.37% | New | Q3 2025 | |
| $9.75M | 3.27% | 0.55% | +10.3% | Q4 2024 | |
| $9.75M | 3.27% | 0.00% | -2.7% | Q2 2022 | |
| $9.59M | 3.22% | Not reported | +42.8% | Q4 2021 | |
| ATAKROAkero Therapeutics, Inc. | $7.08M | 2.38% | 0.19% | New | Q3 2025 |
| $6.88M | 2.31% | 0.00% | +11.5% | Q2 2022 | |
| $6.84M | 2.30% | 0.00% | -5.9% | Q4 2023 | |
| $6.82M | 2.29% | 0.00% | Not reported | Q3 2023 | |
| $6.51M | 2.18% | Not reported | -4.8% | Q1 2022 | |
| $6.19M | 2.08% | 0.04% | -53.9% | Q4 2024 | |
| $5.72M | 1.92% | 0.49% | +6.9% | Q4 2024 | |
| $5.61M | 1.88% | 0.04% | New | Q3 2025 | |
| $5.15M | 1.73% | 0.00% | +80.6% | Q4 2021 | |
| $4.55M | 1.53% | 0.02% | -5.0% | Q1 2025 | |
| $4.3M | 1.44% | 0.00% | -5.5% | Q4 2023 | |
| $4.19M | 1.41% | 0.00% | -5.0% | Q3 2023 | |
| $4M | 1.34% | 0.01% | -4.7% | Q4 2024 | |
| $3.45M | 1.16% | 0.00% | -51.9% | Q1 2025 | |
| $3.2M | 1.08% | 0.00% | Not reported | Q4 2024 | |
| $3.17M | 1.06% | 0.00% | New | Q3 2025 | |
| $3.14M | 1.05% | Not reported | -67.7% | Q2 2025 | |
| $3.13M | 1.05% | 0.02% | -33.1% | Q4 2024 | |
| $3.01M | 1.01% | 0.01% | New | Q3 2025 | |
| $3M | 1.01% | 0.03% | New | Q3 2025 | |
| $2.95M | 0.99% | 0.00% | -1.0% | Q2 2022 | |
| $2.94M | 0.99% | 0.01% | -72.6% | Q4 2024 | |
| $2.78M | 0.93% | 0.12% | -53.2% | Q2 2025 | |
| $2.72M | 0.91% | 0.00% | Not reported | Q1 2022 | |
| $2.6M | 0.87% | 0.00% | -56.6% | Q4 2024 | |
| $2.53M | 0.85% | 0.02% | -62.1% | Q4 2024 | |
| $2.48M | 0.83% | 0.03% | Not reported | Q4 2024 | |
| $2.42M | 0.81% | 0.00% | -35.0% | Q4 2021 | |
| $2.26M | 0.76% | 0.03% | New | Q3 2025 | |
| $2.12M | 0.71% | 0.02% | -7.4% | Q4 2024 | |
| $1.79M | 0.60% | 0.00% | Not reported | Q1 2025 | |
| $1.77M | 0.60% | 0.00% | Not reported | Q2 2024 | |
| $1.39M | 0.47% | 0.01% | Not reported | Q1 2024 | |
| $1.32M | 0.44% | 0.00% | -10.0% | Q4 2021 | |
| $1.3M | 0.44% | 0.00% | +7.2% | Q4 2024 | |
| $1.2M | 0.40% | 0.05% | Not reported | Q1 2025 | |
| $1.17M | 0.39% | 0.01% | New | Q3 2025 | |
Premium opens every quarter this fund has filed